ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine.

IF 1.9 4区医学 Q2 ANESTHESIOLOGY

Acta Anaesthesiologica Scandinavica Pub Date : 2024-10-01 Epub Date: 2024-06-11 DOI:10.1111/aas.14472

Marius Rehn, Michelle S Chew, Maija Kalliomaki, Klaus T Olkkola, Martin Ingi Sigurðsson, Morten Hylander Møller

引用次数: 0

Abstract

Background: The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the clinical practice guideline "ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation." The guideline can provide guidance to Nordic anaesthesiologists on the perioperative use of cardiac biomarkers in patients undergoing non-cardiac surgery.

查看原文本刊更多论文

ESAIC关于在围手术期风险评估中使用心脏生物标记物的重点指南：斯堪的纳维亚麻醉学和重症监护医学会认可。

背景：斯堪的纳维亚麻醉学和重症监护医学会临床实践委员会赞同临床实践指南 "ESAIC 围手术期风险评估中使用心脏生物标记物的重点指南"。该指南可为北欧麻醉医师在非心脏手术患者围术期使用心脏生物标志物提供指导。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Acta Anaesthesiologica Scandinavica 医学-麻醉学

CiteScore

4.30

自引率

9.50%

发文量

157

审稿时长

3-8 weeks

期刊介绍： Acta Anaesthesiologica Scandinavica publishes papers on original work in the fields of anaesthesiology, intensive care, pain, emergency medicine, and subjects related to their basic sciences, on condition that they are contributed exclusively to this Journal. Case reports and short communications may be considered for publication if of particular interest; also letters to the Editor, especially if related to already published material. The editorial board is free to discuss the publication of reviews on current topics, the choice of which, however, is the prerogative of the board. Every effort will be made by the Editors and selected experts to expedite a critical review of manuscripts in order to ensure rapid publication of papers of a high scientific standard.